Evolución de la enfermedad meningocócica en la Comunidad de Madrid. Efectividad de la vacunación antimeningocócica A+C

Gutiérrez Rodríguez, M. Ángeles; Ramírez Fernández, Rosa; García Gutiérrez, Juan; Moreno Civantos, Antonio; Hernando García, Margarita; Arce Arnáez, Araceli; Sendra Gutiérrez, Juan Manuel; Bueno Vallejos, Rafael.
Rev. esp. salud pública ; 74(4): 397-403, jul. 2000.
Artigo em Es | IBECS (Espanha) | ID: ibc-9691

Documentos relacionados

  1. Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
  2. Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study.
  3. Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study.
  4. Evolution of Sequence Type 4821 Clonal Complex Hyperinvasive and Quinolone-Resistant Meningococci.
  5. Good News and Bad News - 4CMenB Vaccine for Group B <i>Neisseria meningitidis</i>.
  6. [Immunogenicity of group A+C meningococcal polysaccharide conjugate vaccine in infants: A phase Ⅲ clinical trial study].
  7. Nurses' preferences regarding MenACWY conjugate vaccines attributes: a discrete choice experiment in Spain.
  8. Investigation of bioluminescence-based assays for determination of kinetic parameters for the bifunctional Neisseria meningitidis serogroup W capsule polymerase.
  9. Informing the use of a supplementary immunisation programme for the management of a community cluster of invasive meningococcal disease, Yorkshire, 2022.
  10. Quantitation of free cyanide using ion exchange chromatography in Neisseria meningitidis serogroups A, C, W, Y and X conjugates used in vaccine manufacture.